Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Magnitude and breadth of neutralizing antibody responses elicited by SARS-CoV-2 infection or vaccination

Benjamin L. Sievers, View ORCID ProfileSaborni Chakraborty, Yong Xue, Terri Gelbart, Joseph C. Gonzalez, Arianna G. Cassidy, Yarden Golan, Mary Prahl, Stephanie L. Gaw, Prabhu S. Arunachalam, Catherine A. Blish, View ORCID ProfileScott D. Boyd, Mark M. Davis, Prasanna Jagannathan, Kari C. Nadeau, Bali Pulendran, Upinder Singh, Richard H. Scheuermann, Matthew Frieman, Sanjay Vashee, View ORCID ProfileTaia T. Wang, Gene S. Tan
doi: https://doi.org/10.1101/2021.12.30.21268540
Benjamin L. Sievers
1J. Craig Venter Institute, La Jolla, CA, and Rockville, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saborni Chakraborty
2Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Saborni Chakraborty
Yong Xue
1J. Craig Venter Institute, La Jolla, CA, and Rockville, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terri Gelbart
1J. Craig Venter Institute, La Jolla, CA, and Rockville, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph C. Gonzalez
2Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA
3Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arianna G. Cassidy
4Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yarden Golan
5Department of Bioengineering and Therapeutic Sciences, and Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Prahl
6Division of Pediatric Infectious Diseases, Department of Pediatrics, University of California, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie L. Gaw
4Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prabhu S. Arunachalam
7Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine A. Blish
2Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA
3Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA
13Chan Zuckerberg Biohub, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott D. Boyd
8Departments of Pathology and of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA USA
11Sean N. Parker Center for Allergy and Asthma Research, Department of Medicine, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Scott D. Boyd
Mark M. Davis
7Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA, USA
9Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA
10Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prasanna Jagannathan
2Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA
9Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kari C. Nadeau
11Sean N. Parker Center for Allergy and Asthma Research, Department of Medicine, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bali Pulendran
7Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Upinder Singh
2Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA
9Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard H. Scheuermann
1J. Craig Venter Institute, La Jolla, CA, and Rockville, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Frieman
12Department of Microbiology and Immunology, Center for Pathogen Research, University of Maryland School of Medicine, Baltimore, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjay Vashee
1J. Craig Venter Institute, La Jolla, CA, and Rockville, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taia T. Wang
2Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA
3Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA
9Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA
13Chan Zuckerberg Biohub, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Taia T. Wang
  • For correspondence: taiawang@stanford.edu gtan@jcvi.org
Gene S. Tan
1J. Craig Venter Institute, La Jolla, CA, and Rockville, MD, USA
14Division of Infectious Diseases, Department of Medicine, University of California San Diego, La Jolla, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: taiawang@stanford.edu gtan@jcvi.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Multiple SARS-CoV-2 variants that possess mutations associated with increased transmission and antibody escape have arisen over the course of the current pandemic. While the current vaccines have largely been effective against past variants, the number of mutations found on the Omicron (B.1.529) spike appear to diminish the efficacy of pre-existing immunity. Using pseudoparticles expressing the spike of several SARS-CoV-2 variants, we evaluated the magnitude and breadth of the neutralizing antibody response over time in naturally infected and in mRNA-vaccinated individuals. We observed that while boosting increases the magnitude of the antibody response to wildtype (D614), Beta, Delta and Omicron variants, the Omicron variant was the most resistant to neutralization. We further observed that vaccinated healthy adults had robust and broad antibody responses while responses were relatively reduced in vaccinated pregnant women, underscoring the importance of learning how to maximize mRNA vaccine responses in pregnant populations. Findings from this study show substantial heterogeneity in the magnitude and breadth of responses after infection and mRNA vaccination and may support the addition of more conserved viral antigens to existing SARS-CoV-2 vaccines.

One Sentence Summary Diminished efficacy of pre-existing immunity to highly mutated SARS-CoV-2 variants.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Conrad Prebys Foundation 204 (RHS, GST) Fast Grants (TTW) CEND COVID Catalyst Fund (TTW) Crown Foundation Sunshine Foundation Marino Family Foundation National Institutes of Health U19AI111825 (TTW) National Institutes of Health U54CA260517 (TTW) National Institutes of Health R01AI137365 (SV) National Institutes of Health R03AI146632 (SV) National Institutes of Health 75N93019C00076 (RHS) BARDA ASPR-20-01495 (MBF) Health and Human Services HHSN272201400008C / 0258-0686-4609 (MBF) Support for Stanford biobanking was supported in part by support from the Quattrone Family and from Fast Grants

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Approved by Institutional Review Board of Stanford University (IRB-556719 and IRB-8629) and the University of California at San Francisco Institutional Review Board (20-32077).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 01, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Magnitude and breadth of neutralizing antibody responses elicited by SARS-CoV-2 infection or vaccination
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Magnitude and breadth of neutralizing antibody responses elicited by SARS-CoV-2 infection or vaccination
Benjamin L. Sievers, Saborni Chakraborty, Yong Xue, Terri Gelbart, Joseph C. Gonzalez, Arianna G. Cassidy, Yarden Golan, Mary Prahl, Stephanie L. Gaw, Prabhu S. Arunachalam, Catherine A. Blish, Scott D. Boyd, Mark M. Davis, Prasanna Jagannathan, Kari C. Nadeau, Bali Pulendran, Upinder Singh, Richard H. Scheuermann, Matthew Frieman, Sanjay Vashee, Taia T. Wang, Gene S. Tan
medRxiv 2021.12.30.21268540; doi: https://doi.org/10.1101/2021.12.30.21268540
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Magnitude and breadth of neutralizing antibody responses elicited by SARS-CoV-2 infection or vaccination
Benjamin L. Sievers, Saborni Chakraborty, Yong Xue, Terri Gelbart, Joseph C. Gonzalez, Arianna G. Cassidy, Yarden Golan, Mary Prahl, Stephanie L. Gaw, Prabhu S. Arunachalam, Catherine A. Blish, Scott D. Boyd, Mark M. Davis, Prasanna Jagannathan, Kari C. Nadeau, Bali Pulendran, Upinder Singh, Richard H. Scheuermann, Matthew Frieman, Sanjay Vashee, Taia T. Wang, Gene S. Tan
medRxiv 2021.12.30.21268540; doi: https://doi.org/10.1101/2021.12.30.21268540

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (420)
  • Anesthesia (97)
  • Cardiovascular Medicine (898)
  • Dentistry and Oral Medicine (169)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (405)
  • Epidemiology (8774)
  • Forensic Medicine (4)
  • Gastroenterology (404)
  • Genetic and Genomic Medicine (1858)
  • Geriatric Medicine (178)
  • Health Economics (387)
  • Health Informatics (1288)
  • Health Policy (644)
  • Health Systems and Quality Improvement (491)
  • Hematology (206)
  • HIV/AIDS (392)
  • Infectious Diseases (except HIV/AIDS) (10549)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1750)
  • Nursing (102)
  • Nutrition (265)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (461)
  • Oncology (963)
  • Ophthalmology (281)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (117)
  • Palliative Medicine (41)
  • Pathology (263)
  • Pediatrics (556)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (218)
  • Psychiatry and Clinical Psychology (1842)
  • Public and Global Health (3977)
  • Radiology and Imaging (652)
  • Rehabilitation Medicine and Physical Therapy (343)
  • Respiratory Medicine (534)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (196)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)